The global health landscape is constantly shifting, with emerging viral threats posing unprecedented challenges to our public health infrastructure. In the wake of COVID-19, groundbreaking scientific and technological innovations have armed us with powerful tools and capabilities, including the revolutionary mRNA vaccine technology. To stay ahead of the curve, a collaborative, forward-thinking approach is crucial. Learn about the initiatives aimed at accelerating vaccine development as part of the 100 Days Mission, a global endeavor to compress vaccine development timelines to 100 days and to ensure access to these vaccines whenever and wherever they are needed.
